ADVERSE EFFECTS OF FIRST LINE ANTITUBERCULOSIS DRUGS IN PATIENTS ON DOTS CAT-1 UNDER REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
Authors: Qureshi D* and Kausar H// PLAGIARISM DETECTED MANUSCRIPT WITHHELD